The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Molecular marker predicts success of breast cancer treatment

A new study demonstrates that the ratio of the expression levels of two genes can be used to accurately predict the clinical outcome of tamoxifen treatment for early stage breast cancer. It is the first method to reliably differentiate between patients who experienced disease-free survival and those at risk for tumor recurrence. The findings also provide new insight into the molecular mechanisms that may contribute to tamoxifen resistance.

Tamoxifen is one of the most widely used therapies for breast cancer. It works by blocking the action of estrogen on breast cancer cells. Estrogen directs the growth of normal breast cells, but can also stimulate the abnormal and unregulated cell growth associated with breast cancer. Unfortunately, nearly 40% of breast cancer patients fail to respond to tamoxifen or eventually become resistant to treatment, and there is no reliable way to predict treatment outcome. Dr. Dennis C. Sgroi from the Pathology Department at Massachusetts General Hospital and Dr. Mark G. Erlander from Arcturus Bioscience, Inc. in Mountain View, California examined the gene expression levels in 60 breast cancers from patients who were treated with tamoxifen after their surgery. Measuring gene expression is a way to examine whether or not a gene is functioning. They discovered that the ratio of the expression levels of two genes, HOXB13 and IL17BR, accurately predicted whether tumors reoccurred after treatment with tamoxifen. The researchers also found that when HOXB13 levels were experimentally elevated in cells from normal breast tissue cultured in the laboratory, the cells showed obvious morphological changes and became more invasive in response to growth signals. "This suggests that HOXB13 may directly contribute to tumor invasion and metastasis," explains Dr. Sgroi.

The researchers conclude that the HOXB13:IL17BR expression ratio may provide an effective molecular marker for identifying breast cancer patients who will be less likely to
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
3-Jun-2004


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Molecular marker predicts success breast cancer treatment

(Date:11/23/2009)...e highest resolution images of peptides attaching ...rstanding how biomolecules manipulate the growth c... for kidney stones using biomolecules. , The res... of the journal Proceedings of the National Acade...th mineral surfaces by accelerating, switching and...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...unprecedented detail how the ribosome interacts wi...ide them toward their destination in biological ce...fitting (MDFF) to examine the interaction of the r... The first study, in Proceedings of the National...ling between the ribosome and an elongation factor...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Does race income predict prostate cancer outcome 3F 60699 1Does race income predict prostate cancer outcome 3F 60699 2Conference explores wide ranging medicinal uses for American ginseng 60697 1OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 1OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 2OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 3
(Date:11/20/2009)... METTLER TOLEDO recently announced tha...ar, “The Role of Process Analytical Technolo...rdquo; on December 1, 2009. , ...Role of Process Analytical Technology (PAT) in Gre...ember 1, Process Analytical Technology (PAT) case ...
(Date:11/19/2009)...ENHAGEN, Nov. 19 Danish Prince Joa...losic ethanol plant in Kalundborg, Denmark, on Wed...rld,s first and largest 2nd generation ethanol dem...nzymes are used in the plant,s innovative process ... of Danisco, was the first to market with commerci...
(Date:11/19/2009)...AUVELT, N.Y., Nov. 19 Dr. Mate Hid...act, responds to a press release issued on Novembe... company for making false and self-serving stateme.... ,, Dr. Hidvegi stated from his office in Bud...research on Avemar does not apply to AveULTRA, w...
(Date:11/19/2009)...W YORK, Nov. 19 NeoStem,...has sent the following letter to its shareholders,...30, 2009, of China Biopharmaceuticals Holdings, In...y based in the People,s Republic of China. The mer...zhou Eyre Pharmaceutical Co. Ltd., CHBP,s primary ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
Other News:
...n gene variant, when carried by cigarette smokers,...eart disease - Britain's single biggest killer.......oundation (BHF), comes from a collaboration betwee...ute at St Bartholemew's Hospital published in THE ...
...ow male dogs come from the other side of the neigh...takes is a few molecules of a certain chemical to ...half-mile away, said Milos Novotny, Distinguished ...te for Pheromone Research at Indiana University......
...r Research Resources (NCRR) at the National Instit...g of a Mutant Mouse Regional Resource Centers (MMR...stop shop for the U.S. biomedical research communi...MMRRC network is now accepting genetic mouse strai...
...fied today before the Senate Appropriations Subcom... for embryonic stem cell research.......Krause, as...logy at Yale School of Medicine, has done extensiv...vered adult stem cells in bone marrow that can cre...
Gene link to increased risk of coronary heart disease found by scientists 2Gene link to increased risk of coronary heart disease found by scientists 3Both smells and pheromones may arouse instinctive behaviors in mammals 2New mutant mouse repositories established for biomedical researcher community 2Yale researcher testifies in support of embryonic stem cell research 2
...w treatment for prostate cancer may provide a dist...nd induce actual regression of the disease--not ju...he disease, according to a study by Italian resear...7 in San Diego.... ..."A new treatment protocol co...
...sing positron emission tomography (PET) to study t...scientists may be getting closer to determining im...anisms involved, according to a group of Danish re...53rd Annual Meeting June 37 in San Diego.... ..."F...
...imaging technology--the use of single photon emiss...aphy (CT) scanners--creates high quality images th...ing to results presented at SNM's 53rd Annual Meet...f bone scintigraphy--or bone scanning--is enhanced...
... cancer only a few years ago, but not before he he... currently called DB-67, recently received approva... patients. The Markey Cancer Center at the Univers... Investigational New Drug status for DB-67 and wil...
New combination treatment induces regression of prostate cancer 2Is being overweight all in the brain? 2Is being overweight all in the brain? 3Getting ahead of cancer: SPECT/Spiral CT technology enhances bone scanning, earlier diagnosis 2UK markey cancer center receives FDA approval to test novel cancer drug 2